BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 25406425)

  • 1. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.
    Filosso PL; Guerrera F; Evangelista A; Welter S; Thomas P; Casado PM; Rendina EA; Venuta F; Ampollini L; Brunelli A; Stella F; Nosotti M; Raveglia F; Larocca V; Rena O; Margaritora S; Ardissone F; Travis WD; Sarkaria I; Sagan D;
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):441-7; discussion 447. PubMed ID: 25564217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.
    Filosso PL; Ruffini E; Di Gangi S; Guerrera F; Bora G; Ciccone G; Galassi C; Solidoro P; Lyberis P; Oliaro A; Sandri A
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):521-6; discussion 526. PubMed ID: 24092506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Filosso PL; Guerrera F; Evangelista A; Galassi C; Welter S; Rendina EA; Travis W; Lim E; Sarkaria I; Thomas PA;
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):339-345. PubMed ID: 28459956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
    Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
    Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
    Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
    Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
    Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Tsutsui H; Ohira T; Ikeda N
    Lung Cancer; 2011 Jun; 72(3):355-9. PubMed ID: 21075474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
    Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
    Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
    Kinoshita T; Yoshida J; Ishii G; Aokage K; Hishida T; Nagai K
    Clin Lung Cancer; 2013 Sep; 14(5):535-40. PubMed ID: 23792008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
    García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
    Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas?
    Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; Zander DS; DeCamp MM
    J Thorac Oncol; 2011 Jun; 6(6):1050-8. PubMed ID: 21566535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-cell neuroendocrine carcinoma of the lung: surgical management.
    Sakurai H; Asamura H
    Thorac Surg Clin; 2014 Aug; 24(3):305-11. PubMed ID: 25065932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.